Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Alpar

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
The Journal of Pharmacy and Pharmacology|March 1, 1992
The use of albumin microspheres in the treatment of carrageenan-induced inflammation in the ratD A Lewis, W N Field, K Hayes, et al.
The Journal of Pharmacy and Pharmacology|March 1, 1989
The transport of microspheres from the gastro-intestinal tract to inflammatory air pouches in the ratH O Alpar, W N Field, R Hyde, et al.
Vaccine|March 10, 1998
Immune responses to V antigen of Yersinia pestis co-encapsulated with IFN-gamma: effect of dose and formulationK F Griffin, B R Conway, H O Alpar, et al.
Journal of Drug Targeting|June 19, 2004
Immunological aspects of polymer microsphere vaccine delivery systemsJ E Eyles, Z C Carpenter, H O Alpar, et al.
The Journal of Pharmacy and Pharmacology|July 1, 1995
The transfer of polystyrene microspheres from the gastrointestinal tract to the circulation after oral administration in the ratJ Eyles, O Alpar, W N Field, et al.
The Journal of Pharmacy and Pharmacology|May 24, 2001
Tissue distribution of radioactivity following intranasal administration of radioactive microspheresJ E Eyles, I D Spiers, E D Williamson, et al.
Vaccine|September 6, 2001
Microsphere translocation and immunopotentiation in systemic tissues following intranasal administrationJ E Eyles, V W Bramwell, E D Williamson, et al.
International Journal of Pharmaceutics|September 30, 1999
Protection of the enzyme L-asparaginase during lyophilisation--a molecular modelling approach to predict required level of lyoprotectantK R Ward, G D Adams, H O Alpar, et al.
Vaccine|June 28, 2000
Protection studies following bronchopulmonary and intramuscular immunisation with yersinia pestis F1 and V subunit vaccines coencapsulated in biodegradable microspheres: a comparison of efficacyJ E Eyles, E D Williamson, I D Spiers, et al.
Journal of Drug Targeting|January 1, 1993
Liposomal (MLV) polymyxin B: physicochemical characterization and effect of surface charge and drug associationS M Lawrence, H O Alpar, S M McAllister, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
The Journal of Pharmacy and Pharmacology|March 1, 1992
The use of albumin microspheres in the treatment of carrageenan-induced inflammation in the ratD A Lewis, W N Field, K Hayes, et al.
The Journal of Pharmacy and Pharmacology|March 1, 1989
The transport of microspheres from the gastro-intestinal tract to inflammatory air pouches in the ratH O Alpar, W N Field, R Hyde, et al.
Vaccine|March 10, 1998
Immune responses to V antigen of Yersinia pestis co-encapsulated with IFN-gamma: effect of dose and formulationK F Griffin, B R Conway, H O Alpar, et al.
Journal of Drug Targeting|June 19, 2004
Immunological aspects of polymer microsphere vaccine delivery systemsJ E Eyles, Z C Carpenter, H O Alpar, et al.
The Journal of Pharmacy and Pharmacology|July 1, 1995
The transfer of polystyrene microspheres from the gastrointestinal tract to the circulation after oral administration in the ratJ Eyles, O Alpar, W N Field, et al.
The Journal of Pharmacy and Pharmacology|May 24, 2001
Tissue distribution of radioactivity following intranasal administration of radioactive microspheresJ E Eyles, I D Spiers, E D Williamson, et al.
Vaccine|September 6, 2001
Microsphere translocation and immunopotentiation in systemic tissues following intranasal administrationJ E Eyles, V W Bramwell, E D Williamson, et al.
International Journal of Pharmaceutics|September 30, 1999
Protection of the enzyme L-asparaginase during lyophilisation--a molecular modelling approach to predict required level of lyoprotectantK R Ward, G D Adams, H O Alpar, et al.
Vaccine|June 28, 2000
Protection studies following bronchopulmonary and intramuscular immunisation with yersinia pestis F1 and V subunit vaccines coencapsulated in biodegradable microspheres: a comparison of efficacyJ E Eyles, E D Williamson, I D Spiers, et al.
Journal of Drug Targeting|January 1, 1993
Liposomal (MLV) polymyxin B: physicochemical characterization and effect of surface charge and drug associationS M Lawrence, H O Alpar, S M McAllister, et al.
Pageof 5